$12.55
0.32[2.62%]
At close: Apr 26
$12.55
0[0.00%]
After Hours: 7:46PM EDT
NovoCure
(NASDAQ:NVCR)Latest News for NovoCure Stock (NASDAQ:NVCR)
NovoCure Stock (NASDAQ: NVCR)
Categories: All
Wednesday, April 24, 2024
Wednesday, April 10, 2024
Wednesday, April 03, 2024
Wednesday, March 27, 2024
- Peeling Back The Layers: Exploring NovoCure Through Analyst InsightsBenzinga Insights - Mar 27, 2024, 4:01PM
- HC Wainwright & Co. Maintains Neutral on NovoCure, Raises Price Target to $24Benzinga Newsdesk - Mar 27, 2024, 1:44PM
- Novocure Stock Soars, Its Lung Cancer Electric Field Treatment Slows Progression To Brain, Data ShowsVandana Singh - Mar 27, 2024, 10:16AM
- Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Mar 27, 2024, 10:03AM
- NovoCure Shares Halted On Circuit Breaker To The Downside, Stock Now Up 1.76%Benzinga Newsdesk - Mar 27, 2024, 9:37AM
- Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating A Extension In Time To Intracranial Progression For Patients With Brain Metastases From Non-Small Cell Lung CancerBenzinga Newsdesk - Mar 27, 2024, 9:30AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Mar 27, 2024, 9:05AM
- Market-Moving News for March 27thBenzinga Newsdesk - Mar 27, 2024, 8:31AM
- Novocure shares are trading higher after the company's METIS Phase 3 trial met primary endpoint, demonstrating statistically significant extension in time to intracranial progression for brain metastases from non-small cell lung cancer.Benzinga Newsdesk - Mar 27, 2024, 7:17AM
- Novocure's METIS Phase 3 Trial Met Primary Endpoint, Demonstrating Statistically Significant Extension In Time to Intracranial Progression For Brain Metastases from Non-Small Cell Lung CancerBenzinga Newsdesk - Mar 27, 2024, 7:09AM
Tuesday, March 12, 2024
Tuesday, February 27, 2024
Thursday, February 22, 2024
- HC Wainwright & Co. Maintains Buy on NovoCure, Raises Price Target to $22Benzinga Newsdesk - Feb 22, 2024, 2:24PM
- NovoCure Limited Shares Halted On Circuit Breaker To The Downside, Stock Now Up 0.19%Benzinga Newsdesk - Feb 22, 2024, 9:34AM
- NovoCure Q4 EPS $(0.45) Beats $(0.52) Estimate, Sales $133.78M Beat $131.19M EstimateBenzinga Newsdesk - Feb 22, 2024, 7:03AM
- Earnings Scheduled For February 22, 2024Benzinga Insights - Feb 22, 2024, 5:27AM
Thursday, January 18, 2024
- AI Drives Tech Rebound, Oil Soars, Bitcoin Tumbles: What's Driving Markets Thursday?Piero Cingari - Jan 18, 2024, 2:22PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Jan 18, 2024, 12:31PM
- Why Is Cancer Focused Novocure Stock Trading Higher Today?Vandana Singh - Jan 18, 2024, 12:19PM
- Fastenal Posts Upbeat Earnings, Joins NovoCure, Taiwan Semiconductor Manufacturing And Other Big Stocks Moving Higher On ThursdayAvi Kapoor - Jan 18, 2024, 10:10AM
- NovoCure shares are trading higher after the company announced FDA acceptance of the PMA application for TTFields therapy in non-small cell lung cancer.Benzinga Newsdesk - Jan 18, 2024, 10:01AM
- Novocure Reports FDA Acceptance Of PMA Application For TTFields Therapy In Non-Small Cell Lung CancerBenzinga Newsdesk - Jan 18, 2024, 7:01AM
Wednesday, January 10, 2024
Tuesday, January 09, 2024
Monday, January 08, 2024
- NovoCure shares are trading higher after the company issued preliminary Q4 and FY23 revenue guidance above estimates.Benzinga Newsdesk - Jan 8, 2024, 1:00PM
- Novocure Announces Preliminary Q4 FY23 Revenues Of $134M Versus Consensus Of $129.30M And $509M For FY23 Versus Consensus Of $505.00MBenzinga Newsdesk - Jan 8, 2024, 8:14AM